Abstract:Enhancing neuronal α7 nicotinic acetylcholine receptor (α7 nAChR) function can alleviate cognitive deficits. Here, we report the design, synthesis, and evaluation of N-(4-(trifluoromethoxy)phenyl)-1,3,5-triazin-2-amine derivatives 8–10 as a series of novel α7 nAChR positive allosteric modulators (PAMs). The representative compound 10e functions as a type I PAM with an EC50 of 3.0 μM and approximately 38-fold enhancement of α7 current in the presence of agonist acetylcholine (100 μM). It specifically enhances α7 current with high selectivity. Compound 10e shows good pharmacokinetic property in mice. Intraperitoneal injection of 10e (3 mg/kg) exhibits sufficient blood–brain barrier penetration in mice. Furthermore, 10e can also rescue the auditory gating deficit in mice with schizophrenia-like behavior. Molecular docking of 10e with homopentameric α7 nAChR reveals a new mode of action. These results support the potential of 10e for treatment for schizophrenia and Alzheimer's disease.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01058.Rat liver microsome stability assessment of test compounds; Individual concentrations of 9d in rats dosed by IV at 1 mg/kg; Individual concentrations of 9d in rats dosed by PO at 10 mg/kg; Individual concentrations of 10d in mice dosed by IV at 1 mg/kg and PO/IP at 3 mg/kg; Individual concentrations of 10e in mice dosed by IV at 1 mg/kg and PO/IP at 3 mg/kg; Selective increase on other subtypes by compound 8l, 9d, and 10e instead of α7 nAChR current; Mean concentrations of 10e in plasma and brain; NMR spectra, HPLC reports and HRMS of the target compounds 8–10 (PDF)PAINS filter using False Positive Remover (PDF)Molecular formula strings of the target compounds (CSV)Docking results of compound 5b with modeled human alpha 7 nAChR (PDB)Docking results of compound 10e with modeled human alpha 7 nAChR (PDB)This article has not yet been cited by other publications.

The Regulating Inotropic Activity of 7-Substituted-Oxy-Benzo[4,5]Thiazolo[2,3-c][1,2,4]Triazole

The regulating inotropic activity of 6-substituted-oxy-[1,2,4]triazolo[3,4-a]phthalazine

Synthesis and Negative Inotropic Effects Evaluation of 7-Substituted-4,5-dihydro-[1,2,4]oxadiazolo[4,3-a]quinolin-1-ones

Design, Synthesis, and Negative Inotropic Evaluation of 4‐phenyl‐1h‐1,2,4‐triazol‐5(4h)‐one Derivatives Containing Triazole or Piperazine Moieties

Synthesis and In-Vitro Inotropic Evaluation of 2-(4-substitutedbenzyl-1,4-diazepan-1-yl)-n-(4,5-dihydro-1-phenyl-[1,2,4 ]Triazolo[4,3-A]quinolin-7-yl)acetamides

Synthesis and Positive Inotropic Activity of [1,2,4]Triazolo[4,3-A] Quinoxaline Derivatives Bearing Substituted Benzylpiperazine and Benzoylpiperazine Moieties.

Synthesis and Positive Inotropic Evaluation of 1-(Benzylamino)-3-(4,5-di-hydro[1,2,4]trizaolo[4,3-a]quinolin-7-yloxy)propan-2-ol Derivatives

Synthesis and biological evaluation of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted benzylpiperazine moieties as positive inotropic agents.

Synthesis and Positive Inotropic Evaluation of [1,2,4]Triazolo[3,4-A]phthalazine and Tetrazolo[5,1-A]phthalazine Derivatives Bearing Substituted Piperazine Moieties

Synthesis of 2-(4-substitutedbenzyl-[1,4]diazepan-1-yl)-n-(1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides As Inotropic Agents.

Synthesis and Positive Inotropic Evaluation of N-(1-oxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides Bearing Piperazine and 1,4-Diazepane Moieties.

Synthesis and inotropic evaluation of 1-substituted-N-(4,5-dihydro-1-methyl-[1,2,4]triazolo[4,3-a]quinolin-7-yl)piperidine-4-carboxamides.

Synthesis of 2-(4-substitutedbenzylpiperazin-1-yl)-n-(2-oxo-2,3-dihydrobenzooxazol-6-yl)acetamides As Inotropic Agents.

Synthesis and Positive Inotropic Evaluation of 2-(4-substituted Benzyl-1,4-Diazepan-1-Yl)-N-(5-Bromoquinoxalin-6-Yl)Acetamides

Synthesis of 2-(4-substituted Benzyl-1,4-Diazepan-1-Yl)-N-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Oxazin-7- Yl)Acetamides and Their Positive Inotropic Evaluation

Synthesis of 2-(4-substitutedmethylpiperazin-1-yl)-n-(3,4-dihydro-3-oxo-2h-benzo[b][1,4]oxazin-7-yl)acetamides and Their Positive Inotropic Evaluation.

Synthesis and positive inotropic activity of N-(4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)-2-(piperazin-1-yl)acetamide derivatives.

ChemInform Abstract: Synthesis and in Vitro Inotropic Evaluation of 2-(4-substitutedbenzyl-1,4-diazepan-1-yl)-n-(4,5-dihydro-1-phenyl [1,2,4]Triazolo[4,3-A]quinolin-7-yl)acetamides.

Synthesis of new triazole acetamides with inotropic effects.

ChemInform Abstract: Synthesis and Positive Inotropic Evaluation of (e)‐2‐(4‐cinnamylpiperazin‐1‐yl)‐n‐(1‐substituted‐4,5‐dihydro [1,2,4]Triazolo[4,3‐a]quinolin‐7‐yl)acetamides.

Synthesis and Biological Evaluation of Novel Triazine Derivatives as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors